The Supreme Court ruled that Myriad Genetics cannot patent the naturally occurring BRCA1 and BRCA2 breast cancer-related genes, opening the door to competitors, but Myriad still holds data on various mutations. Free the Data, a collaboration between nonprofit and for-profit organizations, is asking patients who had the Myriad genetic test to share the reports they received with their genetic results, which Free the Data will compile and make available for free online for researchers, patients and clinicians.

Full Story:
Bio-IT World

Related Summaries